AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2024
Jan 6, 2024
32180_dirs_2024-01-05_96bb15cc-8f0a-47f1-889d-62b6f25a312a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2024-01-03
Reporting Person: Smith Jeffrey T L (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are beneficially owned | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.00 | 2033-01-04 | Common Stock (188000) | Direct |
Footnotes
F1: Stock options vest as follows: (i) 25% of underlying shares of common stock on January 5, 2024 (the first anniversary of grant date) and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of each month following first anniversary of grant date.